30m
Seattle biotech looks to raise up to $288 million amid plans to spin out immune medicine business
The company said in a regulatory filing that separating its two business lines "would enable each to pursue its distinct ...
Aaron Johnson, the company’s vice president of finance and accounting, will assume the role of interim CFO effective July 9.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results